Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8943044 | 1.00 | TSHR (0.48) | TSHRALDH1A1LMNATDP1DNM1 | |
| SCHEMBL8668923 | 0.98 | TSHR (0.50) | TSHRALDH1A1LMNATDP1DNM1 | |
| SCHEMBL18107414 | 0.98 | TSHR (0.50) | TSHRALDH1A1LMNATDP1DNM1 | |
| SCHEMBL18107222 | 0.98 | TSHR (0.50) | TSHRALDH1A1LMNATDP1DNM1 | |
| SCHEMBL18107286 | 0.98 | TSHR (0.50) | TSHRALDH1A1LMNATDP1DNM1 | |
| SCHEMBL18107312 | 0.98 | TSHR (0.50) | TSHRALDH1A1LMNATDP1DNM1 | |
| SCHEMBL18107448 | 0.98 | TSHR (0.50) | TSHRALDH1A1LMNATDP1DNM1 | |
| SCHEMBL18107366 | 0.98 | TSHR (0.50) | TSHRALDH1A1LMNATDP1DNM1 | |
| SCHEMBL18107229 | 0.95 | TSHR (0.48) | TSHRALDH1A1LMNATDP1DNM1 | |
| SCHEMBL18107205 | 0.95 | TSHR (0.48) | TSHRALDH1A1LMNATDP1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10597298-B2 | Ceramic encapsulation by use of one or more specialized silanes to template oil in an oil in water emulsion | CoLabs International Corporation (US) | 2020-03-24 | — | — | US | disclosed |
| US-20180037464-A1 | Ceramic Encapsulation by Use of One or More Specialized Silanes to Template Oil in an Oil in Water Emulsion | CoLabs International Corporation (US) | 2018-02-08 | — | — | US | disclosed |
| US-9822010-B2 | Ceramic encapsulation by use of one or more specialized silanes to template oil in an oil in water emulsion | CoLabs International Corporation (US) | 2017-11-21 | — | — | US | disclosed |
| US-8110225-B2 | Treatment using dantrolene | LYOTROPIC THERAPEUTICS, INC. (US) | 2012-02-07 | — | — | US | disclosed |
| US-20110256304-A1 | Ceramic Encapsulation By Use of One or More Specialized Silanes To Template Oil In An Oil In Water Emulsion | ASC DISSOLUTION CORPORATION | 2011-10-20 | — | — | US | disclosed |
| US-20100160400-A1 | TREATMENT USING DANTROLENE | LYOTROPIC THERAPEUTICS, INC. (US) | 2010-06-24 | — | — | US | disclosed |